Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 0 | 0 | 0 | 9,514 | 417 |
| Gross Profit | N/A | N/A | N/A | 9,514 | 417 |
| Operating Expenses | 11,022 | 13,007 | 16,835 | 16,357 | 18,415 |
| Operating Income | -11,022 | -13,007 | -16,835 | -6,843 | -17,998 |
| Interest Expense | 89 | 95 | 125 | 158 | 199 |
| Other Income | -8,656 | 677 | -9 | 97 | 293 |
| Pre-tax Income | -19,767 | -12,425 | -16,969 | -6,904 | -17,904 |
| Net Income Continuous | -19,767 | -12,425 | -16,969 | -6,904 | -17,904 |
| Minority Interests | 0 | 59,998 | -7,229 | -5,190 | -2,877 |
| Net Income | $-19,767 | $-72,423 | $-9,740 | $-1,714 | $-15,027 |
| EPS Basic Total Ops | -3.90 | -19.50 | -2.90 | -0.50 | -4.60 |
| EPS Basic Continuous Ops | -3.95 | -3.35 | -5.12 | -2.09 | -5.45 |
| EPS Diluted Total Ops | -3.90 | -19.50 | -2.90 | -0.50 | -4.60 |
| EPS Diluted Continuous Ops | -3.95 | -3.35 | -5.12 | -2.09 | -5.45 |
| EBITDA(a) | $-9,789 | $-11,745 | $-15,597 | $-5,571 | $-16,740 |